Meta-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease Inhibitors
- 1 February 1997
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (4) , 506-514
- https://doi.org/10.1021/jm960583g
Abstract
The design, synthesis, and biochemical profile of meta-substituted benzofused macrocyclic lactams are described. The meta-substituted benzofused macrocyclic lactams were designed to have a degree of flexibility allowing the amide bond to occupy two completely different conformations while maintaining sufficient rigidity to allow for strong interaction between enzyme and inhibitor. Using TFIT, a novel molecular superimposition program, it was shown that the meta analogs could be readily superimposed onto our ACE inhibitor template whereas no low-energy superimpositions of the ortho-substituted macrocycles could be found. The macrocycles were prepared by tethering aldehyde 1 derived from S-glutamic acid or S-aspartic acid to a meta-substituted phosphonium bromide 2. Homologation to a monocarboxylic acid methyl ester malonate followed by deprotection and cyclization gave the macrocyclic frame. Further manipulation gave the desired compounds. Unlike the ortho-substituted benzofused macrocyclic lactams described in the previous paper which are selective NEP inhibitors, the meta-substituted compounds are dual inhibitors of both NEP and ACE. The most potent member of this new series, compound 16a, inhibited both enzymes with an IC50 = 8 nM in NEP and 4 nM in ACE.Keywords
This publication has 29 references indexed in Scilit:
- Three-Dimensional Models of ACE and NEP Inhibitors and Their Use in the Design of Potent Dual ACE/NEP InhibitorsJournal of the American Chemical Society, 1996
- Crystal structures of matrilysin-inhibitor complexesBiochemistry, 1995
- Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitorsJournal of Medicinal Chemistry, 1993
- Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc‐binding environments (HEXXHXXGXXH and Met‐turn) and topologies and should be grouped into a common family, the ‘metzincins’FEBS Letters, 1993
- Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11Journal of Medicinal Chemistry, 1993
- Crystallographic studies of angiotensin converting enzyme inhibitors and analysis of preferred zinc coordination geometryJournal of Medicinal Chemistry, 1990
- Zinc coordination, function, and structure of zinc enzymes and other proteinsBiochemistry, 1990
- A unique signature identifies a family of zinc‐dependent metallopeptidasesFEBS Letters, 1989
- Exploration of the catalytic site of endopeptidase 24.11 by site‐directed mutagenesis Histidine residues 583 and 587 are essential for catalysisFEBS Letters, 1988
- A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studiesJournal of Computer-Aided Molecular Design, 1987